2. Paz, M., de Alencar, M., de Lima, R., Sobral, A., do Nascimento, G., Dos Reis, C. A., Coêlho, M., do Nascimento, M., Gomes Júnior, A. L., Machado, K., de Menezes, A., de Lima, R., de Oliveira Filho, J., Dias, A., Dos Reis, A. C., da Mata, A., Machado, S. A., Sousa, C., da Silva, F., Islam, M. T., … Melo Cavalcante, A. (2020). Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer. Oxidative medicine and cellular longevity, 2020, 3457890. https://doi.org/10.1155/2020/3457890
3. Li, W., Zeng, S., Yu, L. S., & Zhou, Q. (2013). Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management. Therapeutics and clinical risk management, 9, 259–271. https://doi.org/10.2147/TCRM.S43151